CompletedNot Applicable

The Experiences of Patients Living With Malignant Pleural Effusions

United Kingdom10 participantsStarted 2016-06-02

Plain-language summary

Up to 20 patients with malignant pleural effusions will be interviewed about their experiences of having this condition and its management.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Adults diagnosed with a malignant pleural effusion
✓. Has undergone either talc pleurodesis or IPC
✓. Have signed a consent form prior to entering the study
✓. Life expectancy \> 6 weeks based on LENT guidelines (Low/Moderate risk group) - The LENT score calculation assigns 0 (\<1500 IU/L) or 1 (\>1500 IU/L) for pleural fluid LDH level; 0 to 3 points for matching ECOG performance scores (3 and 4 are combined); 0 (\<9) or 1 (\>9) for neutrophil-to-lymphocyte ratio; and 0 (lowest risk), 1 (moderate risk), or 3 (highest risk) for tumor type.

✕. Any patient who is unable to understand sufficient English to take part in the semi-structured interviews
✕. Weakness or fatigue sufficient so that the patient is unable to take part in the interviews

Patient Experiences of living with malignant pleural effusion and different pleural procedures

Timeframe: 4 weeks after IPC placement or talc pleurodesis

NCT IDNCT03235999

SponsorGloucestershire Hospitals NHS Foundation Trust

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-01